1Department of Mathematical Sciences, Virginia Commonwealth University, Richmond 23284-2014, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study introduces a two-stage Bayesian phase II clinical trial design to improve therapeutic agent selection and efficacy assessment. Simulations show this approach is a promising alternative to traditional fixed-sample-size methods.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: